HomeCompareSDAD vs JNJ

SDAD vs JNJ: Dividend Comparison 2026

SDAD yields 2116.40% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SDAD wins by $16850188636.05M in total portfolio value
10 years
SDAD
SDAD
● Live price
2116.40%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$16850188636.07M
Annual income
$15,417,192,906,367,192.00
Full SDAD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SDAD vs JNJ

📍 SDAD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSDADJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SDAD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SDAD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SDAD
Annual income on $10K today (after 15% tax)
$179,894.18/yr
After 10yr DRIP, annual income (after tax)
$13,104,613,970,412,112.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SDAD beats the other by $13,104,613,970,411,408.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SDAD + JNJ for your $10,000?

SDAD: 50%JNJ: 50%
100% JNJ50/50100% SDAD
Portfolio after 10yr
$8425094318.04M
Annual income
$7,708,596,453,184,010.00/yr
Blended yield
91.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SDAD
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SDAD buys
0
JNJ buys
0
No recent congressional trades found for SDAD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSDADJNJ
Forward yield2116.40%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$16850188636.07M$20.0K
Annual income after 10y$15,417,192,906,367,192.00$827.78
Total dividends collected$16748912801.47M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SDAD vs JNJ ($10,000, DRIP)

YearSDAD PortfolioSDAD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$222,340$211,640.21$10,676$355.77+$211.7KSDAD
2$4,635,673$4,397,769.11$11,407$389.39+$4.62MSDAD
3$90,652,793$85,692,623.21$12,198$426.53+$90.64MSDAD
4$1,663,129,343$1,566,130,853.69$13,056$467.62+$1663.12MSDAD
5$28,632,319,033$26,852,770,636.14$13,987$513.12+$28632.31MSDAD
6$462,688,385,745$432,051,804,380.31$14,998$563.56+$462688.37MSDAD
7$7,020,130,708,021$6,525,054,135,273.67$16,098$619.52+$7020130.69MSDAD
8$100,036,081,369,040$92,524,541,511,456.90$17,295$681.69+$100036081.35MSDAD
9$1,339,248,345,515,456$1,232,209,738,450,583.50$18,599$750.82+$1339248345.50MSDAD
10$16,850,188,636,068,730$15,417,192,906,367,192.00$20,022$827.78+$16850188636.05MSDAD

SDAD vs JNJ: Complete Analysis 2026

SDADStock

SH Resources & Development Corp. operates in the specialty finance industry. The company is based in Beverly Hills, California.

Full SDAD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SDAD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SDAD vs SCHDSDAD vs JEPISDAD vs OSDAD vs KOSDAD vs MAINSDAD vs ABBVSDAD vs MRKSDAD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.